These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6359885)

  • 1. Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study.
    Piver MS; Barlow JJ; Vongtama V; Blumenson L
    Am J Obstet Gynecol; 1983 Dec; 147(7):803-8. PubMed ID: 6359885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancer.
    Piver M; Khalil M; Emrich LJ
    J Surg Oncol; 1989 Oct; 42(2):120-5. PubMed ID: 2796346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix.
    Piver MS; Barlow JJ; Vongtama V; Blumenson L
    Am J Obstet Gynecol; 1977 Oct; 129(4):379-83. PubMed ID: 410296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer.
    Piver MS; Vongtama V; Emrich LJ
    J Surg Oncol; 1987 Jun; 35(2):129-34. PubMed ID: 3108586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea.
    Piver MS; Krishnamsetty RM; Emrich LJ
    Am J Obstet Gynecol; 1985 Apr; 151(8):1006-8. PubMed ID: 3985061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
    Stehman FB; Bundy BN; Keys H; Currie JL; Mortel R; Creasman WT
    Am J Obstet Gynecol; 1988 Jul; 159(1):87-94. PubMed ID: 3293456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix.
    Stehman FB
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):48-52. PubMed ID: 1641657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery.
    Fine BA; Hempling RE; Piver MS; Baker TR; McAuley M; Driscoll D
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):717-23. PubMed ID: 7860382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
    Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
    N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: a preliminary report.
    Xynos FP; Benjamin I; Sapiente R; Rana MW; Nalesnik WJ
    Gynecol Oncol; 1980 Apr; 9(2):170-6. PubMed ID: 7372189
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
    Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
    Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.
    Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C
    Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
    Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
    J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
    Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
    Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
    Marnitz S; Köhler C; Burova E; Wlodarczyk W; Jahn U; Grün A; Budach V; Stromberger C
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e137-43. PubMed ID: 21600704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
    Stehman FB; Bundy BN; Thomas G; Keys HM; d'Ablaing G; Fowler WC; Mortel R; Creasman WT
    J Clin Oncol; 1993 Aug; 11(8):1523-8. PubMed ID: 8336190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
    Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.